Ticker
GLUECompany Name
MONTE ROSA THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Market Capitalization | Net Cash Flow - Issuance (Purchase) of Equity Shares | Net Cash Flow - Dividends & Other Cash Distributions | Payout Yield |
---|---|---|---|---|
6/30/2025 | $ 261.24M | $ 1M | $ 0 | -0.38% |
3/31/2025 | $ 259.57M | $ 98.66M | $ 0 | -38.01% |
12/31/2024 | $ 434.26M | $ 98.89M | $ 0 | -22.77% |
9/30/2024 | $ 585.49M | $ 98.57M | $ 0 | -16.84% |
6/30/2024 | $ 244.26M | $ 99.66M | $ 0 | -40.8% |
3/31/2024 | $ 261.65M | $ 2.84M | $ 0 | -1.08% |
12/31/2023 | $ 305.44M | $ 2.61M | $ 0 | -0.85% |
9/30/2023 | $ 165.27M | $ 22.75M | $ 0 | -13.77% |
6/30/2023 | $ 331.72M | $ 21.43M | $ 0 | -6.46% |
3/31/2023 | $ 288.89M | $ 20.33M | $ 0 | -7.04% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
(-1 * CF - Equity -1 * CF - Dividends) / Market Cap
(=) Payout Yield
Payout Yield for MONTE ROSA THERAPEUTICS INC is calculated as follows: (-1 * CF - Equity [ $ 0 ] -1 * CF - Dividends [ $ 0 ]) / Market Cap [ $ 0 ]
(=) Payout Yield [ 0% ]
Minimum
Mar 31, 2022
Maximum
Sep 30, 2022
Average
Median
filtered constituents | 3.53K |
---|---|
min | -15.69% |
max | 16.92% |
average | 1.82% |
median | 1.33% |
std | 5.1% |